安德森癌症中心招聘免疫学、微生物学方向的访问学者和博士后

  安德森癌症中心招聘免疫学、微生物学方向的访问学者和博士后,以下是厚谱教育为您收集整理的安德森癌症中心招聘免疫学、微生物学方向的访问学者和博士后的详细信息。

  A postdoctoral fellowship position is immediately available in the Laboratory of Scott Evans at the University of Texas MD Anderson Cancer Center. Pneumonias are a leading cause of death in all populations, and exact a particularly severe toll on immunocompromised individuals, such as cancer patients receiving cytotoxic therapies. In an effort to protect vulnerable patients against lethal pneumonias, the Evans lab investigates means to manipulate the lungs’ intrinsic antimicrobial defenses to protect against the pathogens that people inhale or aspirate every day. Rather than rely on the canonical responses of leukocytes that are often deficient or dysfunctional in cancer patients, the focus of our work is on manipulating microbicidal responses directly from lung epithelial cells, a long-lived cell population that is largely tolerant of cytotoxic therapies. Using this approach, the Evans lab has discovered epithelium-focused immunostimulatory therapies that are now in FDA-approved clinical trials in a variety of settings. Our work now focuses on understanding how this manipulation can prevent both acute (lethal pneumonia) and chronic (asthma) complications of respiratory infections. Such understanding can allow development of next-generation therapies that exert even greater efficacy with even fewer off-target effects. Active projects in the laboratory include investigations into novel mechanisms to detect pathogens, into mechanisms of intra- and inter-cellular signaling events that promote synergistic protective responses, into the inducible microbicidal effector mechanisms that reduce pathogen burdens, and into immunomodulatory effects of our epithelial treatments that exert their effects independent of pathogen burden.

  The Evans lab has “shovel ready” projects for postdoctoral fellows to lead on day one, but given the unconventional nature of the lab’s programs, applicants’ novel ideas for new projects are also encouraged. The Evans lab strives to be inclusive and supports a highly collaborative, team-oriented, learner-driven environment.

  Successful applicants must have MD and/or PhD degrees with experience in immunology, microbiology, epithelial biology or other fields directly relevant to host-pathogen interactions. Postdoctoral fellows should be familiar with basic cell biology and immunology techniques. Strong written and spoken English communication skills are important to the positions, as successful applicants will participate in writing grants and papers, will present findings and novel research in various formats, and will provide supervision to more junior trainees. Experience with small rodents is a plus.

  M.D.安德森癌症中心(MD Anderson Cancer Center),始建于1941年,位于美国南部德克萨斯州的休斯顿市,是世界公认的权威的肿瘤专科医院,是1971年美国“国家癌症行动”计划指定的最早的3个综合癌症治疗中心之一,也是目前39个肿瘤医学会指定的综合性癌症治疗中心之一; 是世界一流的癌症诊治、研究中心。

  M.D.安德森癌症中心共有18000多名员工,其中1500多名医生,病床500余张,每年收治美国和其他国家的住院患者19000余例,日门诊量1800人次。从1944年到现在,已经有超过79000名癌症患者在M.D.安德森癌症中心接受治疗,其中约1/3来自德克萨斯州之外。并且有超过11000例患者参加了M.D.安德森癌症中心的临床研究试验。

  在2008年度总共接诊90000名癌症病人,其中30000名是新病人,分布在93个国家和地区,其中不乏各国的政要和商业精英。例如韩国首富三星集团前董事长李健熙(Kun-Hee Lee)于2000年因肺癌至安德森癌症中心接受手术和后续治疗。

  该中心为癌症患者提供的治疗包括靶向疗法、手术、化疗、放疗和质子疗法、免疫疗法以及多种疗法的联合治疗。跨学科的专家团队通过密切合作为患者制定最佳的治疗方案。

  安德森癌症中心每年投资超过4亿美元进行医学基础研究,并且拥有最多的美国国家癌症研究院(NCI)资助研究项目。2005年,M.D.安德森癌症中心的科研经费高达3.42亿美元。中心目前拥有10个NCI优势研究项目的资助,包括:脑瘤、胰腺癌、乳腺癌、膀胱癌、前列腺癌、白血病、卵巢癌、子宫内膜癌、肺癌和黑色素瘤。每年都有1100多位临床住院医生到MD安德森癌症中心接受癌症研究和治疗的专业培训。

  安德森癌症中心多年来一直为中国肿瘤医生提供学习世界上最先进技术的机会,几乎国内各个著名医院都有医生到安德森癌症中心进修过。中国各大知名医院许多肿瘤专家均曾在安德森癌症中心进修学习。例如,中国肿瘤排名第一的医科院肿瘤医院专家孙燕院士等。